Sarfaraz K. Niazi
Informa Healthcare
Hardback
550
39326
As the generic pharmaceutical industry continues to grow and thrive, so does the need to conduct efficient and successful bioequivalence studies. In recent years, there have been significant changes to the statistical models for evaluating bioequivalence